- Home
- ALLY vs PEN Comparison
ALLY vs PEN Comparison
Compare ALLY & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLY
- PEN
- Stock Information
- Founded
- ALLY 1919
- PEN 2004
- Country
- ALLY United States
- PEN United States
- Employees
- ALLY N/A
- PEN N/A
- Industry
- ALLY Major Banks
- PEN Medical/Dental Instruments
- Sector
- ALLY Finance
- PEN Health Care
- Exchange
- ALLY Nasdaq
- PEN Nasdaq
- Market Cap
- ALLY 12.0B
- PEN 10.6B
- IPO Year
- ALLY 2014
- PEN 2015
- Fundamental
- Price
- ALLY $44.18
- PEN $258.16
- Analyst Decision
- ALLY Buy
- PEN Strong Buy
- Analyst Count
- ALLY 18
- PEN 16
- Target Price
- ALLY $45.07
- PEN $302.93
- AVG Volume (30 Days)
- ALLY 2.5M
- PEN 463.3K
- Earning Date
- ALLY 10-17-2025
- PEN 10-29-2025
- Dividend Yield
- ALLY 2.77%
- PEN N/A
- EPS Growth
- ALLY N/A
- PEN 916.05
- EPS
- ALLY 1.04
- PEN 3.74
- Revenue
- ALLY $6,852,000,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- ALLY $19.77
- PEN $15.52
- Revenue Next Year
- ALLY $14.41
- PEN $14.20
- P/E Ratio
- ALLY $41.83
- PEN $70.20
- Revenue Growth
- ALLY 1.11
- PEN 12.92
- 52 Week Low
- ALLY $29.52
- PEN $184.80
- 52 Week High
- ALLY $43.42
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- ALLY 80.44
- PEN 44.21
- Support Level
- ALLY $40.83
- PEN $270.54
- Resistance Level
- ALLY $41.97
- PEN $280.14
- Average True Range (ATR)
- ALLY 0.79
- PEN 7.61
- MACD
- ALLY 0.24
- PEN -2.68
- Stochastic Oscillator
- ALLY 99.02
- PEN 0.00
About ALLY Ally Financial Inc.
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.